Literature DB >> 17437107

FDOPA PET has clinical utility in brain tumour imaging: a proposal for a revision of the recent EANM guidelines.

Jean-Noël Talbot, Khaldoun Kerrou, Françoise Montravers, Valérie Nataf, Yanna Chevalme.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17437107     DOI： 10.1007/s00259-007-0400-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   10.057


× No keyword cloud information.
  4 in total

1.  EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues.

Authors:  T Vander Borght; S Asenbaum; P Bartenstein; C Halldin; O Kapucu; K Van Laere; A Varrone; K Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11       Impact factor: 9.236

2.  F-Dopa as an amino acid tracer to detect brain tumors.

Authors:  W D Heiss; K Wienhard; R Wagner; H Lanfermann; A Thiel; K Herholz; U Pietrzyk
Journal:  J Nucl Med       Date:  1996-07       Impact factor: 10.057

3.  18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.

Authors:  Wei Chen; Daniel H S Silverman; Sibylle Delaloye; Johannes Czernin; Nirav Kamdar; Whitney Pope; Nagichettiar Satyamurthy; Christiaan Schiepers; Timothy Cloughesy
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

4.  Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine.

Authors:  Alexander Becherer; Georgios Karanikas; Monica Szabó; Georg Zettinig; Susanne Asenbaum; Christine Marosi; Christine Henk; Patrick Wunderbaldinger; Thomas Czech; Wolfgang Wadsak; Kurt Kletter
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-23       Impact factor: 9.236
  4 in total
  4 in total

1.  Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas.

Authors:  Cécile Colavolpe; Philippe Metellus; Julien Mancini; Maryline Barrie; Céline Béquet-Boucard; Dominique Figarella-Branger; Olivier Mundler; Olivier Chinot; Eric Guedj
Journal:  J Neurooncol       Date:  2011-12-15       Impact factor: 4.130

Review 2.  Metabolic positron emission tomography imaging in cancer detection and therapy response.

Authors:  Aizhi Zhu; Daniel Lee; Hyunsuk Shim
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

Review 3.  Current molecular imaging positron emitting radiotracers in oncology.

Authors:  Aizhi Zhu; Hyunsuk Shim
Journal:  Nucl Med Mol Imaging       Date:  2011-02-01

Review 4.  Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma.

Authors:  Aurélie Moreau; Olivia Febvey; Thomas Mognetti; Didier Frappaz; David Kryza
Journal:  Front Oncol       Date:  2019-11-01       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.